Ajanta Pharma Ltd AJANTPHARM
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹3,270.60
- Day Range
- ₹3,224.30–3,349.60
- 52-Week Range
- ₹2,382.00–3,796.00
- Bid/Ask
- ₹3,283.90 / ₹3,283.90
- Shares Outstanding
- 124.96M
- Market Cap
- ₹410.35B
- Volume/Avg
- 154,847 / 92,321
Key Statistics
- Price/Earnings (Normalized)
- 35.42
- Price/Sales
- 7.11
- Dividend Yield (Trailing)
- 1.83%
- Dividend Yield (Forward)
- 1.95%
- Dividend Payment Schedule
- Aug, Nov
- Total Yield
- 1.83%
Company Profile
Ajanta Pharma Ltd is mainly involved in development, manufacturing and marketing of speciality pharmaceutical finished dosages. The operations of the Group are limited to only one segment viz. pharmaceuticals and related products. The company has presence in India, Emerging Market, Africa Institution, and USA. The company generates majority of revenue from Emerging market.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 13,206
- Website
- https://www.ajantapharma.com
Valuation
|
Metric
|
AJANTPHARM
|
|---|---|
Price/Earnings (Normalized) | 35.42 |
Price/Book Value | 9.07 |
Price/Sales | 7.11 |
Price/Cash Flow | 35.09 |
Price/Earnings
AJANTPHARM
Financial Strength
|
Metric
|
AJANTPHARM
|
|---|---|
Quick Ratio | 1.88 |
Current Ratio | 2.64 |
Interest Coverage | 107.44 |
Quick Ratio
AJANTPHARM
Profitability
|
Metric
|
AJANTPHARM
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
AJANTPHARM
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|&%Yqg?c | LOCK|>TW?# | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|%btN^CfZ | LOCK|NNC< | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|>J#H>W# | LOCK|mRJ | $45B | |||
| Zoetis Inc Class A
ZTS
| LOCK|n#@Vq># | LOCK|!x | $33B | |||
| Viatris Inc
VTRS
| LOCK|#&!W$&^ | LOCK|XN | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|??@ | LOCK|&^ | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|jTCfb$^ | LOCK|yW | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|mHM>m>H | LOCK|^x | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|fdqZxrN | LOCK|$WDDn | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|D#CmVZ? | LOCK|@Sy | $2B |
United States